BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| DL-α-Glycerophosphate | DL-α-Glycerophosphate is a renowned chemical compound with a remarkable attribute of DL-α-Glycerophosphate liying in its pivotal role as a substrate in enzymatic determinations of alkaline phosphatase activity. Unveiling its vast potential, DL-α-Glycerophosphate holds promise in the research of critical ailments, such as osteoporosand other grave bone-related disorders. Group: Pharmaceutical. CAS No. 57-03-4. Pack Sizes: 100 g. Product ID: B1370-027988. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| DL-α-Hydroxystearic acid | 2-Hydroxyoctadecanoic acid is a natural product found in Allamanda cathartica, Brassica napus, and other organisms. It plays a crucial role as an intermediate in the production of several other fatty acids, such as linoleic acid, oleic acid, and arachidonic acid. Group: Pharmaceutical. CAS No. 629-22-1. Pack Sizes: 500 mg. Product ID: B1370-190468. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Leu(14)-Semaglutide | D-Leu(14)-Semaglutide is an impurity of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: B1370-449829. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DL-Glyceraldehyde-[1,2,3-13C3] | DL-Glyceraldehyde-[1,2,3-13C3] is an isotope form of Glyceraldehyde, which is the simplest of all aldoses and has been shown to be the one of the carbonyl metabolite of dietary fructose. Group: Pharmaceutical. CAS No. 478529-56-5. Pack Sizes: 250 mg. Product ID: BLP-013196. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DLinDMA | DLinDMA, an ionizable cationic lipid, is a key lipid component of stable nucleic acid lipid particles (SNALPs) as a benchmark. Group: Pharmaceutical. CAS No. 871258-12-7. Pack Sizes: 100 mg. Product ID: B4059-051365. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DLin-KC2-DMA | DLin-KC2-DMA is a cationic/ionizable lipid for siRNA delivery. DLin-KC2-DMA was formulated and characterized in SNALP and demonstrated to have in vivo activity at siRNA doses as low as 0.01 mg/kg in rodents and 0.1 mg/kg in nonhuman primates. Group: Pharmaceutical. CAS No. 1190197-97-7. Pack Sizes: 10 mg. Product ID: B4059-291966. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Lin-MC3-DMA | D-Lin-MC3-DMA is the most potent cationic lipid that has been synthesized for lipid nanoparticles (LNPs) to deliver the siRNA. D-Lin-MC3-DMA is useful for design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. LNP systems containing D-Lin-MC3-DMA can be highly effective, non-toxic pDNA delivery systems for gene expression both in vitro and in vivo. Group: Pharmaceutical. CAS No. 1224606-06-7. Pack Sizes: 25 mg. Product ID: B4059-291965. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DLin-MC4-DMA | DLin-MC4-DMA is a cationic lipid which can be used for delivery of nucleic acids. Group: Pharmaceutical. CAS No. 1226909-66-5. Pack Sizes: 50 mg. Product ID: B1370-427866. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DL-Phe(4-Ac)-OH HCl | DL-Phe(4-Ac)-OH HCl is a highly versatile chemical compound with a wide range of research applications, most notably in the fields of neurodegeneration and pain management. This modified form of phenylalanine, which features an additional acetyl group, represents a key building block for the synthesis of numerous pharmaceuticals. Thanks to its fascinating properties, including potential anti-tumor and neuroprotective effects, it has been intensively studied as a promising candidate for future drug development. Group: Pharmaceutical. CAS No. 1360436-95-8. Pack Sizes: 1 g. Product ID: BAT-008861. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DL-Tetrahydroberberine | Tetrahydroberberine is a protoberberine alkaloid which potently block functional KATP channels natively expressed on midbrain dopamine neurons. Tetrahydroberberine is used for treatment of degenerative diseases or conditions associated with KATP channel signaling. Group: Pharmaceutical. CAS No. 522-97-4. Pack Sizes: 10 mg. Product ID: B2703-464701. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Luciferin | D-Luciferin is a chemiluminescent substrate for luciferases. D-Luciferin produces fluorescence upon oxidation by luciferase in the presence of ATP. Group: Pharmaceutical. CAS No. 2591-17-5. Pack Sizes: 1 g. Product ID: B1370-088744. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Luciferin potassium salt | D-Luciferin potassium salt is a chemiluminescent substrate of firefly luciferase. Group: Pharmaceutical. CAS No. 115144-35-9. Pack Sizes: 5 g. Product ID: B2708-081982. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Lys(20)-Semaglutide | D-Lys(20)-Semaglutide is an impurity of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: B1370-449833. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DM1-SMCC | DM1 with a reactive linker SMCC, which can react with antibody to make antibody drug conjugate, as a potent EGFR inhibitor and it overcomes resistant to EGFR. Uses: This active molecular is dm1 with a linker smcc that can react with antibody to make antibody drug conjugate. Group: Pharmaceutical. CAS No. 1228105-51-8. Pack Sizes: 10 mg. Product ID: BBF-04656. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DM1-SMe | DM1-SMe is a potent maytansinoid microtubular inhibitor and an unconjugated DM1 as a mixed disulfide with thiomethane to cap its sulfhydryl group. DM1-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). Group: Pharmaceutical. CAS No. 138148-68-2. Pack Sizes: 25 mg. Product ID: BADC-00020. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DM1-SPP | DM1 with a reactive linker SPP, which can react with antibody to make antibody drug conjugate, as a potent EGFR inhibitor and it overcomes resistant to EGFR. Group: Pharmaceutical. CAS No. 452072-20-7. Pack Sizes: 5 mg. Product ID: BADC-00010. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DM3 | DM3 is a cytotoxic agent. It is used as the cytotoxic component in antibody-drug conjugates. Group: Pharmaceutical. CAS No. 796073-54-6. Pack Sizes: 5 mg. Product ID: BADC-00339. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DM3-SMe | DM3-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). Group: Pharmaceutical. CAS No. 796073-70-6. Pack Sizes: 5 mg. Product ID: BADC-00022. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DM4 | DM4 is an anti-tubulin agent that inhibits cell division. DM4 can be used to prepare antibody-drug conjugates. DM4 binds to tubulin at the maytansine-binding site, disrupting microtubule assembly/disassembly dynamics and inhibiting mitosis. Group: Pharmaceutical. CAS No. 796073-69-3. Pack Sizes: 5 mg. Product ID: BBF-05778. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DM4-SMe | DM4-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). Group: Pharmaceutical. CAS No. 796073-68-2. Pack Sizes: 5 mg. Product ID: BADC-00021. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DM4-SPDB | DM4 with a reactive linker SPDB, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site. Group: Pharmaceutical. CAS No. 1626359-62-3. Pack Sizes: 1 mg. Product ID: BADC-00012. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DM4-SPDP | DM4 with a reactive linker SPDP, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site. Group: Pharmaceutical. CAS No. 2245698-48-8. Pack Sizes: 1 mg. Product ID: BADC-00011. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DMAE-NHS | As a chemiluminescent agent for direct chemiluminescence immunoanalysis, it is used for the detection and analysis of antigens, antibodies, proteins, etc. Group: Pharmaceutical. CAS No. 115853-74-2. Pack Sizes: 5 mg. Product ID: B2708-047159. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Mannosamine HCl | D-Mannosamine HCl, a paramount substance pervasively utilized in the biomedical sector, assumes a pivotal role. Its multifaceted properties enable its extensive application towards mitigating an array of ailments and disorders. Within the realm of pharmaceutical advancements, this compound assumes a critical function, facilitating the creation of antiviral pharmaceuticals, antibiotics, and anticancer therapeutics. Invaluable therapeutic implementations encompass combatting viral infections, impeding bacterial proliferation, and efficacious cancer control. The prodigious potential of D-Mannosamine HCl emerges as an instrumental asset in propelling cutting-edge biomedical exploration, thus catalyzing revolutionary drug discoveries. Group: Pharmaceutical. CAS No. 5505-63-5. Pack Sizes: 10 g. Product ID: B2705-302402. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-mannuronic acid sodium | D-Mannuronic Acid Sodium Salt is a vital component used in the production of alginate hydrogels for drug delivery applications in biomedicine. It serves as a crosslinker, enhancing the stability and controlled release of various drugs to study conditions such as cancer, bacterial infections, and cardiovascular diseases. Group: Pharmaceutical. CAS No. 921-56-2. Pack Sizes: 10 mg. Product ID: B2705-334166. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Methionine methylsulfonium bromide | D-Methionine methylsulfonium bromide, a compound renowned for its efficacy in countering acetaminophen-induced liver injury, has also emerged as a promising candidate for shielding against cisplatin-induced nephrotoxicity. Group: Pharmaceutical. CAS No. 212757-14-7. Pack Sizes: 5 mg. Product ID: B2692-102087. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DMOG | DMOG is an antagonist of α-ketoglutarate cofactor and inhibitor for HIF prolyl hydroxylase. Group: Pharmaceutical. CAS No. 89464-63-1. Pack Sizes: 1 g. Product ID: B1370-140847. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DMPE-PEG | DMPE-PEG, a polyethylene glycol derivative, is a vital component in the development of advanced drug delivery platforms focused on combatting cancer and infectious diseases. Through its unique properties, it plays a crucial role in improving the solubility and stability of pharmaceutical agents, thereby heightening their therapeutic potential. Group: Pharmaceutical. CAS No. 474922-82-2. Pack Sizes: 100 mg. Product ID: B4059-291961. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DMRIE | DMRIE. Group: Pharmaceutical. CAS No. 153312-64-2. Pack Sizes: 1 mg. Product ID: BRH-005. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DMU-212 | DMU-212, an orally active methylated derivative of Resveratrol, has antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. It induces mitotic arrest by inducing apoptosis and activating ERK1/2 protein. Group: Pharmaceutical. CAS No. 134029-62-2. Pack Sizes: 500 mg. Product ID: B1370-236170. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DMXAA | DMXAA is a STING agonist that induces antitumor immunological responses. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 117570-53-3. Pack Sizes: 25 mg. Product ID: B0084-082134. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (D)-(+)-Neopterin | Neopterin, a pyrazino-pyrimidine compound derived from GTP, n is a precursor of tetrahydrobiopterin and can be used as a biochemical marker indicative of cell proliferation. Neopterin is synthesized in response to interferon-γ stimulation, and used as a marker of T helper cell-induced immune activation. Neopterin is also an indicator of oxidative stress, and modulates the effects of reactive oxygen species (ROS). Group: Pharmaceutical. CAS No. 2009-64-5. Pack Sizes: 100 mg. Product ID: B2693-070923. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dnp-Pro-Leu-Gly-Leu-Trp-Ala-DArg-NH2 | Dnp-Pro-Leu-Gly-Leu-Trp-Ala-DArg-NH2, a peptide utilized for biological research, is an exemplary agent for evaluating proteolytic activity and inhibitor effects. Notably, its potential in disease treatment, encompassing cancer and inflammation, has put it at the forefront of therapeutic development. In addition to its promising therapeutic properties, Dnp-Pro-Leu-Gly-Leu-Trp-Ala-DArg-NH2 may serve as a vital diagnostic tool for identifying pertinent enzymes within biological samples, providing otherwise unattainable insights for investigative purposes. Group: Pharmaceutical. CAS No. 121282-17-5. Pack Sizes: 10 mg. Product ID: BAT-006194. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dobutamine hydrochloride | Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of β1 receptors of the sympathetic nervous system. Group: Pharmaceutical. CAS No. 49745-95-1. Pack Sizes: 2 g. Product ID: B0084-069664. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dobutamine Impurities | Dobutamine Impurities are critical for quality control in the production of Dobutamine, a prominent drug used to treat acute heart failure and cardiogenic shock. They provide insights into the drug's synthesis, ensuring efficacy and safety, thus facilitating research on cardiac conditions and advancing therapeutic applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Docarpamine | Docarpamine is a prodrug of dopamine. Group: Pharmaceutical. CAS No. 74639-40-0. Pack Sizes: 250 mg. Product ID: B2692-132334. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Docetaxel | Docetaxel, also called Taxoltere metro, a semisynthetic side-chain analogue of taxol differing at two positions in its chemical structure, is an inhibitior of microtubule disassembly (IC50 = 0.2 μM). And it inhibits cell replication (IC50 = 0.13 μM). Uses: Antitumor. Group: Pharmaceutical. CAS No. 114977-28-5. Pack Sizes: 5 g. Product ID: NP3347. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Docetaxel Impurities | Docetaxel Impurities, recognized in the biomedical industry, play a crucial role in the quality control of Docetaxel, an essential chemotherapeutic agent for treating various cancers, including breast, lung, and prostate cancers. These impurities must be identified and quantified to ensure the efficacy and safety of the pharmaceutical formulation. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Docosahexaenoic acid | Docosahexaenoic acid (DHA) is an omega-3 fatty acid found in fish oil and a major component of excitable membranes of the retina and brain. It decreases the level of blood triglycerides and reduces the risk of cardiovascular disorders. Nutritional supplement in health care products. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 6217-54-5. Pack Sizes: 1 g. Product ID: BBF-05818. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Docosan-1-amine | Docosan-1-amine is a drug substance that belongs to the class of monocarboxylic acids. Group: Pharmaceutical. CAS No. 14130-06-4. Pack Sizes: 250 mg. Product ID: BB009169. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Docosanedioic acid | Behenic acid, or docosanedioic acid, a saturated fatty acid, is an effective emollient in the cosmetics industry due to its remarkable moisturizing properties. Behenic acid's therapeutic potential is another aspect of interest, as it has been researched for the treatment of various maladies, including multiple sclerosis and Parkinson's disease. Moreover, it is demonstrated to have a positive impact on chondrogenesis, which is vital for the formation of cartilage tissue due to its exceptional proliferative force. It is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. Group: Pharmaceutical. CAS No. 505-56-6. Pack Sizes: 5 g. Product ID: BADC-01934. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Docusate Impurities | Docusate Impurities hold paramount importance in pharmaceutical quality assurance, especially in the synthesis of docusate sodium, an extensively utilized stool softener. Monitoring purity levels and identifying these impurities are crucial for preserving therapeutic effectiveness and ensuring safety in alleviating constipation, ultimately safeguarding patient health without detriment. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dodecyl 2-(N,N-dimethylamino)propionate hydrochloride | Dodecyl 2-(N,N-dimethylamino)propionate hydrochloride, a quaternary ammonium compound, finds extensive use as a phase transfer catalyst to create novel drugs and chemical substances. It also serves as a surfactant in biomedical experiments that enhances drug solubility and effectiveness. Its exceptional attribute of crossing the blood-brain barrier suggests future potential in neurological and psychiatric therapies. Group: Pharmaceutical. CAS No. 259685-49-9. Pack Sizes: 250 mg. Product ID: B0001-306554. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dodecyl acetate | Dodecyl acetate is a main component of the essential oil from the flowers of Etlingera elatior (Jack) R. M. Smith, which is found to be active against Staphylococcus aureus, Bacillus cereus, Candida albicans and Cryptococcus neoformans. Group: Pharmaceutical. CAS No. 112-66-3. Pack Sizes: 1 L. Product ID: B1370-295523. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dodecyl b-D-glucopyranoside | Dodecyl b-D-glucopyranoside: A surfactant commonly used in the biomedical industry for various applications. It is utilized in drug formulation and gene delivery systems due to its ability to solubilize hydrophobic drugs. Additionally, it plays a crucial role in cell lysis, protein extraction, and enzyme stabilization. It is also employed in biochemistry and biotechnology research for the purification and analysis of glycoproteins and glycolipids. Group: Pharmaceutical. CAS No. 59122-55-3. Pack Sizes: 5 g. Product ID: B2693-095117. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dodecylguanidine hydrochloride | Dodecylguanidine is used as an antibacterial agent and an antifungal agrochemical. Group: Pharmaceutical. CAS No. 13590-97-1. Pack Sizes: 1 g. Product ID: B2693-083526. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dodecylphosphocholine | Dodecylphosphocholine is a structural analogue of lauroyl lysophosphatidylcholine which is more stable to hydrolytic degradation. Group: Pharmaceutical. CAS No. 29557-51-5. Pack Sizes: 1 g. Product ID: B0001-062762. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dodovislactone B | Dodovislactone B is extracted from the aerial parts of Dodonaea viscosa. Group: Pharmaceutical. CAS No. 1616683-55-6. Pack Sizes: 1 mg. Product ID: NP1600. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dodovisone B | Dodovisone B is extracted from the aerial parts of Dodonaea viscosa. Group: Pharmaceutical. CAS No. 1616683-51-2. Pack Sizes: 1 mg. Product ID: NP2099. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dofetilide Impurities | Dofetilide Impurities, integral chemical byproducts, feature prominently in the stringent quality control and formulation processes of the antiarrhythmic agent, dofetilide. Their meticulous examination ensures both safety and therapeutic efficacy, critical as dofetilide modulates cardiac ion channels preventing atrial fibrillation and atrial flutter, thereby enhancing cardiovascular treatment paradigms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dolasetron Impurities | Dolasetron impurities, integral reference standards within the biomedical sphere, are paramount for ensuring stringent quality control and safety evaluations in Dolasetron production. This drug, pivotal in mitigating chemotherapy-induced nausea and vomiting, necessitates impurity analysis to guarantee both therapeutic effectiveness and patient safety, underscoring its criticality in medical practice. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dolastatin 10 | Dolastatin 10 is a potent antimitotic peptide from a marine animal, strongly inhibiting microtubule assembly. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 110417-88-4. Pack Sizes: 5 mg. Product ID: BAT-010469. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dolutegravir | Dolutegravir is a two-metal-binding HIV-1 integrase inhibitor with IC50 of 2.7 nM, with modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. It blocks the strand transfer step of the integration of the viral genome into the host cell (INSTI). Group: Pharmaceutical. CAS No. 1051375-16-6. Pack Sizes: 25 mg. Product ID: B0084-438457. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dolutegravir sodium | Dolutegravir sodium salt is a HIV integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. Uses: Hiv integrase inhibitors. Group: Pharmaceutical. CAS No. 1051375-19-9. Pack Sizes: 500 mg. Product ID: B2693-463509. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Domiphen Impurities | Domiphen Impurities, serving as vital reference standards, underpin the biomedical sector's analytical assessments and quality assurance of domiphen compositions. These impurities are crucial for guaranteeing the purity and therapeutic efficiency of domiphen-containing antiseptics, widely applied in oral health maintenance to thwart bacterial presence and uphold hygienic oral conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Domperidone Impurities | Domperidone Impurities fundamentally impact pharmaceutical practices by assuring the integrity and safety of domperidone-based treatments designed for gastrointestinal disorders, including nausea and gastroparesis. Examination of these impurities facilitates the refinement of manufacturing methodologies, augments drug efficacy, and deepens comprehension of potential adverse effects, thus underpinning medical safety and therapeutic success. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Domperidone Impurity E | An impurity of the gastrokinetic and antinauseant drug Domperidone. Group: Pharmaceutical. CAS No. 1346602-50-3. Pack Sizes: 10 mg. Product ID: B2694-470354. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Domperidone Impurity F | An impurity of the gastrokinetic and antinauseant drug Domperidone. Group: Pharmaceutical. CAS No. 1391053-55-6. Pack Sizes: 50 mg. Product ID: B2694-470355. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Donepezil | Donepezil, also called Aricept, a centrally acting reversible acetyl cholinesterase inhibitor that the FDA has also approved for the treatment of moderate to severe Alzheimer's disease. It readily crosses the blood-brain barrier to reduce the breakdown of acetylcholine by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. Group: Pharmaceutical. CAS No. 120014-06-4. Pack Sizes: 50 g. Product ID: B2692-082304. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Donepezil Alkene Pyridine N-Oxide | Donepezil Alkene Pyridine N-Oxide is an impurity of Donepezil, a medication for the treatment of Alzheimer's disease. Group: Pharmaceutical. CAS No. 896134-06-8. Pack Sizes: 100 mg. Product ID: B0794-284905. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Donepezil hydrochloride | Donepezil is a specific and potent AChE inhibitor for bAChE and hAChE with IC50 of 8.12 nM and 11.6 nM , respectively. Uses: Cholinesterase inhibitors. Group: Pharmaceutical. CAS No. 120011-70-3. Pack Sizes: 100 mg. Product ID: NP3421. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Donepezil Impurities | Donepezil Impurities are integral to the biomedical field, serving as analytical benchmarks to ascertain the quality and efficacy of donepezil, a treatment predominantly for Alzheimers. These impurities are vital in the pharmacological analysis and refinement of donepezil formulations, contributing to the advancement of therapeutic efficacy in neurodegenerative conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Donepezil Impurity 3 | Donepezil impurity. Group: Pharmaceutical. CAS No. 1023500-88-0. Pack Sizes: 100 mg. Product ID: B0794-470383. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Donepezil Open-Ring Keto Acid | Donepezil Open-Ring Keto Acid is an impurity of Donepezil, a medication for the treatment of Alzheimer's disease. Group: Pharmaceutical. CAS No. 197010-25-6. Pack Sizes: 100 mg. Product ID: B0794-117683. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Donepezil related compound A | (2E)-Dehydrodonepezil is a derivative of Donepezil. Group: Pharmaceutical. CAS No. 145546-80-1. Pack Sizes: 100 mg. Product ID: B0794-470376. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dopa Impurities | Dopa Impurities play a critical role in the biomedical industry by offering insights into the stability, synthesis, and degradation of levodopa formulations used in Parkinson's disease therapy, enhancing the quality assurance of pharmacological interventions. Studying these impurities aids in optimizing drug efficacy and safety profiles for Parkinson's patients. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DOPE | DOPE, also known as 1,2-Dioleoyl-sn-glycero-3-PE or 1,2-DOPE, is a synthetic analog of naturally-occurring PE containing 18:1 fatty acids at the sn-1 and sn-2 positions. 1,2-DOPE can be used as an emulsifier to facilitate DNA-liposome complex transport across membranes. It is used in combination with cationic phospholipids to increase efficiency during DNA transfection studies as a non-viral method of gene delivery. Group: Pharmaceutical. CAS No. 4004-5-1. Pack Sizes: 1 g. Product ID: B4059-163865. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DOPE-PEG-FA ammonium salt | DOPE-PEG-FA is a heterobifunctional PEGylation reagent with an unsaturated DOPE phospholipid and a folic acid. It can be used in targeted drug delivery with the lipid bilayer. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-383268. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Doramectin | Doramectin is a derivative of ivermectin, which is an anthelmintic. Doramectin is an antiparasitic antibiotic produced by Streptomyces. Group: Pharmaceutical. CAS No. 117704-25-3. Pack Sizes: 25 g. Product ID: BBF-03802. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Doramectin Impurities | Doramectin Impurities represent a cornerstone in biomedical exploration, crucial for assessing the quality and efficacy of doramectin therapies. They facilitate the detection of metabolites and degradation byproducts, ensuring therapeutic reliability, vital for parasitic infection treatments, extending their importance to both veterinary and prospective human applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.